Podcast thumbnail for First Rounders

First Rounders

Claim This Podcast

by Nature Biotechnology

5.0(3 reviews)
61 episodes
Updated Daily
Accepts GuestsHas SponsorsLocation 🇺🇸

Podcast Overview

Nature Biotechnology's First Rounders podcast is a series of conversations with founders, financers and developers from biotech's past, present and future.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>

Language

🇺🇲

Publishing Since

3/7/2013

12 verified contact emails on file for First Rounders

Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.

Recent Episodes

Episode thumbnail for Good Bye

May 4, 2022

Good Bye

Host Brady Huggett bids farewell, reflecting on his journey and the podcast's future.

Episode thumbnail for Jay Keasling

April 1, 2022

Jay Keasling

Professor Jay Keasling shares his journey from Nebraska farm to biotech innovator, discussing the future of biofuels in this interview with Nature Biotechnology.

Episode thumbnail for Ingmar Hoerr

February 1, 2022

Ingmar Hoerr

Ingmar Hoerr, co-founder and former CEO of CureVac, shares his journey from RNA discovery to securing venture financing and how a brain aneurysm reshaped his life perspective in this interview with Nature Biotechnology.

61 total episodes available

Recent guests on First Rounders

Guests from recent episodes — sign up to see every guest that has ever appeared on this show.

Jay Keasling

Guest

Ingmar Hoerr

Guest

Lita Nelsen

Guest

Anthony Atala

Guest

Nancy Simonian

Guest

Carl June

Guest

Craig Mello

Guest

Neil Kumar

Guest

Deep-dive analytics for First Rounders

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is First Rounders?

Nature Biotechnology's First Rounders podcast is a series of conversations with founders, financers and developers from biotech's past, present and future.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>

How often does this podcast release new episodes?

This podcast updates daily.

Where can I listen to this podcast?

This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Does this podcast accept guests?

Yes, this podcast regularly features guests.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.